Anemia during sequential induction chemotherapy and chemoradiation for head and neck cancer: the impact of blood transfusion on treatment outcome. (avaa uuden ikkunan)

Bhide SA, Ahmed M, Rengarajan V, Powell C, Miah A, Newbold K, Nutting CM, Harrington KJ.

Lähde‎: Int J Radiat Oncol Biol Phys 2009;73(2):391-8.

Arkistoitu‎: PubMed 18692326

DOI‎: 10.1016/j.ijrobp.2008.04.052

https://www.ncbi.nlm.nih.gov/pubmed/18692326 (avaa uuden ikkunan)

Transfusion as a predictor of recurrence and survival in head and neck cancer surgery patients. (avaa uuden ikkunan)

Chau JK, Harris JR, Seikaly HR.

Lähde‎: J Otolaryngol Head Neck Surg 2010;39(5):516-22.

Arkistoitu‎: PubMed 20828514

https://www.ncbi.nlm.nih.gov/pubmed/20828514 (avaa uuden ikkunan)

Does transfusion improve the outcome for HNSCC patients treated with radiotherapy?—results from the randomized DAHANCA 5 and 7 trials. (avaa uuden ikkunan)

Hoff CM, Lassen P, Eriksen JG, Hansen HS, Specht L, Overgaard M, Grau C, Johansen J, Bentzen J, Andersen L, Evensen JF, Overgaard J.

Lähde‎: Acta Oncol 2011;50(7):1006-14.

Arkistoitu‎: PubMed 21790306

DOI‎: 10.3109/0284186X.2011.592650

https://www.ncbi.nlm.nih.gov/pubmed/21790306 (avaa uuden ikkunan)

Transfusion of allogenic leukocyte-depleted packed red blood cells is associated with postoperative morbidity in patients undergoing oral and oropharyngeal cancer surgery. (avaa uuden ikkunan)

Perisanidis C, Dettke M, Papadogeorgakis N, Schoppmann A, Mittlböck M, Kyzas PA, Ewers R, Seemann R.

Lähde‎: Oral Oncol 2012;48(4):372-8.

Arkistoitu‎: PubMed 22182932

DOI‎: 10.1016/j.oraloncology.2011.11.020

https://www.ncbi.nlm.nih.gov/pubmed/22182932 (avaa uuden ikkunan)